T1	Treatment 30 66	YM17E, an inhibitor of acyl coenzyme
T2	Treatment 191 210	dose study of YM17E
T3	Treatment 447 649	YM17E was administered after a meal to two groups of subjects (each containing six subjects taking the drug and three taking placebo) receiving 3, 60 and 300 mg or 15, 60 and 450 mg YM17E, respectively.
T4	Treatment 898 903	YM17E
T5	Treatment 1158 1164	YM17E.
T6	Treatment 1384 1396	150 mg YM17E
T7	Treatment 1634 1663	test drug at 150 mg or 300 mg
T8	Treatment 1680 1707	placebo (n = 3) twice a day
T9	Treatment 1794 1810	YM17E once a day
